Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02608879 · ClinicalTrials.gov registry record · NA

Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT02608879 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02608879, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of a novel oral care protocol on the severity and pain of oral mucositis in patients receiving radiation and/or chemotherapy for head and neck cancers. The secondary objectives are to characterize the microbiome associated with oral mucositis, measure salivary proinflammatory cytokines, and evaluate other clinical indicators of the intervention. Participants will be enrolled prior to beginning radiation and/or chemotherapy, and will be randomized to receive either the oral health protocol or standard of care oral hygiene.

Interventions

  • OTHER Chlorhexidine
  • PROCEDURE Oral Mucosa Deterging and Periodontal Debridement (OMDP)
  • PROCEDURE Standard of Care Oral Hygiene Instructions
  • PROCEDURE Dental scaling, ultrasonic

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2014-03
Est. Completion 2015-09
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02608879

The ClinicalTrials.gov registry entry for NCT02608879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Chlorhexidine is the first listed.

NCT02608879 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02608879 about?

NCT02608879 is a clinical study titled "Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis". The purpose of this study is to determine the effects of a novel oral care protocol on the severity and pain of oral mucositis in patients receiving radiation and/or chemotherapy for head and neck cancers. The secondary objectives are to characterize the microbiome associated with oral mucositis, me...

What is the current status of trial NCT02608879?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2014-03. Estimated completion is 2015-09.

What interventions are being tested in trial NCT02608879?

The interventions under investigation include: Chlorhexidine (OTHER), Oral Mucosa Deterging and Periodontal Debridement (OMDP) (PROCEDURE), Standard of Care Oral Hygiene Instructions (PROCEDURE), Dental scaling, ultrasonic (PROCEDURE).

Who is sponsoring clinical trial NCT02608879?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.